| Product Code: ETC13208619 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Cannabis Pharmaceutical Market was valued at USD 9.6 Billion in 2024 and is expected to reach USD 18.9 Billion by 2031, growing at a compound annual growth rate of 10.50% during the forecast period (2025-2031).
The Global Cannabis Pharmaceutical Market is experiencing significant growth driven by increasing legalization of medical cannabis and rising acceptance of its therapeutic benefits. Key factors contributing to market expansion include the growing prevalence of chronic diseases, such as cancer and neurological disorders, for which cannabis-based treatments offer promising outcomes. The market is witnessing a surge in research and development activities aimed at exploring the potential of cannabis-derived compounds in addressing various health conditions. Moreover, the shifting regulatory landscape and evolving consumer preferences towards natural remedies are further propelling market growth. Key players in the global cannabis pharmaceutical market are focusing on product innovation, strategic collaborations, and geographical expansion to capitalize on the expanding market opportunities and establish a strong foothold in the industry.
The Global Cannabis Pharmaceutical Market is experiencing significant growth driven by the increasing acceptance of medical cannabis, growing legalization across various regions, and expanding research on the therapeutic benefits of cannabis compounds. Key trends include the development of novel cannabis-based pharmaceutical products for various medical conditions, the integration of technology in cannabis drug delivery systems, and the emergence of new market players entering the cannabis pharmaceutical space. Opportunities lie in leveraging the potential of cannabinoids for treating a wide range of conditions such as chronic pain, epilepsy, and mental health disorders, as well as expanding into untapped markets with evolving regulatory landscapes. Collaborations between pharmaceutical companies and cannabis producers, advancements in extraction and formulation techniques, and strategic partnerships for clinical trials are key strategies for capitalizing on the growth prospects in the global cannabis pharmaceutical market.
The Global Cannabis Pharmaceutical Market faces several challenges including regulatory hurdles and varying legal landscapes across different countries, which can hinder the growth and expansion of cannabis-based pharmaceutical products. Additionally, there is a lack of standardized dosing and delivery methods for cannabis medicines, leading to inconsistencies in treatment outcomes and patient experiences. Research and development costs are also high due to the complex nature of cannabis compounds and the need for clinical trials to establish efficacy and safety profiles. Furthermore, stigma surrounding cannabis as a recreational drug can impact the acceptance and adoption of cannabis-based pharmaceuticals by healthcare professionals and patients. Overall, navigating these challenges requires a coordinated effort from industry stakeholders, policymakers, and healthcare providers to ensure the successful integration of cannabis pharmaceuticals into mainstream healthcare systems.
The global cannabis pharmaceutical market is primarily driven by the increasing legalization of medical cannabis in various countries, growing acceptance of cannabis as a therapeutic option for a range of medical conditions, and the expanding research and development activities focused on leveraging the medicinal properties of cannabis. Additionally, the rising prevalence of chronic diseases such as cancer, multiple sclerosis, and chronic pain, where cannabis-based products have shown potential benefits, is fueling the demand for cannabis pharmaceuticals. Moreover, the shift towards alternative treatment options and the increasing awareness among patients and healthcare professionals regarding the potential benefits of cannabis-based medicines are further propelling the growth of the market. Regulatory approvals for new cannabis-based products and the emergence of innovative delivery methods are also contributing to the market expansion.
Various countries have implemented policies related to the global cannabis pharmaceutical market. In the United States, the legalization of medical marijuana in several states has led to a growing market for cannabis-based pharmaceutical products. Canada has legalized both medical and recreational cannabis, creating a significant market for cannabis pharmaceuticals. In Europe, countries like Germany have established medical cannabis programs, while others are exploring legalization for medical purposes. Additionally, countries in Latin America, such as Colombia and Uruguay, have legalized cannabis for medical and research purposes, attracting investments in the cannabis pharmaceutical industry. Overall, government policies around the world are gradually evolving to accommodate the growing demand and potential of the global cannabis pharmaceutical market.
The Global Cannabis Pharmaceutical Market is poised for significant growth in the coming years, driven by increasing legalization of medical cannabis, growing acceptance of the therapeutic benefits of cannabis-based products, and expanding research and development activities in the pharmaceutical industry. With a shift towards more personalized and targeted treatment approaches, cannabis-derived pharmaceuticals are gaining traction for various medical conditions such as chronic pain, epilepsy, and cancer. Additionally, advancements in extraction and formulation technologies are enhancing the efficacy and safety of cannabis-based medications, further fueling market expansion. As regulatory barriers continue to evolve and more countries embrace medical cannabis, the market is expected to witness robust growth, presenting opportunities for pharmaceutical companies, research institutions, and investors to capitalize on this burgeoning sector.
In the global cannabis pharmaceutical market, North America leads in terms of market share due to the legalization of medical cannabis in various states and the presence of key players in the region. Europe is also witnessing significant growth with increasing acceptance of medical cannabis and regulatory approvals for cannabis-based products. In Asia, the market is gradually opening up with countries like Thailand and South Korea legalizing medical cannabis for certain conditions. The Middle East and Africa region is slowly exploring the potential of cannabis pharmaceuticals, with Israel leading in research and development. Latin America is emerging as a key market with countries like Colombia and Uruguay legalizing cannabis for medical and recreational use, presenting opportunities for growth in the pharmaceutical sector.
Global Cannabis Pharmaceutical Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Cannabis Pharmaceutical Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Global Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Global Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Global Cannabis Pharmaceutical Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Global Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.9 Global Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Global Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Global Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Cannabis Pharmaceutical Market Trends |
6 Global Cannabis Pharmaceutical Market, 2021 - 2031 |
6.1 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Capsules, 2021 - 2031 |
6.1.3 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Concentrates, 2021 - 2031 |
6.1.4 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Edibles, 2021 - 2031 |
6.2 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Epidiolex, 2021 - 2031 |
6.2.3 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Marinol, 2021 - 2031 |
6.2.4 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Cesamet, 2021 - 2031 |
6.2.5 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Sativex, 2021 - 2031 |
6.3 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Tetrahydrocannabinol (THC), 2021 - 2031 |
6.3.3 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Cannabidiol (CBD), 2021 - 2031 |
6.3.4 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Balanced THC & CBD, 2021 - 2031 |
6.4 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Inflammation, 2021 - 2031 |
6.4.3 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Chronic Pain, 2021 - 2031 |
6.4.4 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Epilepsy, 2021 - 2031 |
6.4.5 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Sleep Disorders, 2021 - 2031 |
6.4.6 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Anorexia, 2021 - 2031 |
6.4.7 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Schizophrenia, 2021 - 2031 |
6.5 Global Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Clinic, 2021 - 2031 |
6.5.3 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.6 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.6.3 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.6.4 Global Cannabis Pharmaceutical Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Cannabis Pharmaceutical Market, Overview & Analysis |
7.1 North America Cannabis Pharmaceutical Market Revenues & Volume, 2021 - 2031 |
7.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.5 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
7.6 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7 North America Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Cannabis Pharmaceutical Market, Overview & Analysis |
8.1 Latin America (LATAM) Cannabis Pharmaceutical Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Cannabis Pharmaceutical Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
8.5 Latin America (LATAM) Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
8.6 Latin America (LATAM) Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
8.7 Latin America (LATAM) Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.8 Latin America (LATAM) Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Cannabis Pharmaceutical Market, Overview & Analysis |
9.1 Asia Cannabis Pharmaceutical Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Cannabis Pharmaceutical Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
9.5 Asia Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
9.6 Asia Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
9.7 Asia Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.8 Asia Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Cannabis Pharmaceutical Market, Overview & Analysis |
10.1 Africa Cannabis Pharmaceutical Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Cannabis Pharmaceutical Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
10.5 Africa Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
10.6 Africa Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
10.7 Africa Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.8 Africa Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Cannabis Pharmaceutical Market, Overview & Analysis |
11.1 Europe Cannabis Pharmaceutical Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Cannabis Pharmaceutical Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
11.5 Europe Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
11.6 Europe Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
11.7 Europe Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.8 Europe Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Cannabis Pharmaceutical Market, Overview & Analysis |
12.1 Middle East Cannabis Pharmaceutical Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Cannabis Pharmaceutical Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Cannabis Pharmaceutical Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
12.5 Middle East Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
12.6 Middle East Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
12.7 Middle East Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.8 Middle East Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Cannabis Pharmaceutical Market Key Performance Indicators |
14 Global Cannabis Pharmaceutical Market - Export/Import By Countries Assessment |
15 Global Cannabis Pharmaceutical Market - Opportunity Assessment |
15.1 Global Cannabis Pharmaceutical Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
15.4 Global Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
15.5 Global Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
15.6 Global Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.7 Global Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Cannabis Pharmaceutical Market - Competitive Landscape |
16.1 Global Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
16.2 Global Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |